Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Christiana Care Health Services
• Collaborator: Sage Products, Inc.
• Treatments: Chlorhexidine; Chlorhexidine gluconate; Methicillin

Criteria

Inclusion Criteria:

• All patients admitted to the medical intensive care unit (ICU) are eligible for inclusion

Exclusion Criteria:

• Patient refusal

• Contraindication to nasal swabbing (arm 1)

• Allergy/sensitivity to chlorhexidine gluconate (CHG) (arm 2)